A new study Nike Roshe One N7 released on November 7, 2011 will provide a big boost to Yaz and Yasmin blood clot claims filed in U.S. courts.  The study reviewed the health records of 330,000 Israeli women, and found that the use of Yaz or Yasmin dramatically increased the risk of blood clots, strokes, pulmonary embolisms and deep vein thrombosis.  The study was organized by Dr. Naomi Gronich, of the Technion-Israel Institute of Technology.

This new study will prove significant in the U.S. courts, because all courts require the plaintiffs in these lawsuits to prove, using scientific evidence, that the Yaz or Yasmin birth control pills actually caused their blood clot problems.  Typically, this burden of proof on the causation issue is met using epidemiological studies — studies that compare groups who took a certain drug to groups who didn’t take the drug, and then calculate whether there was a statistically significant increase in the occurrence of a given disease or adverse event among the drug-using group.  If the study proves that the drug-using group was more than twice as likely to develop the disease, the U.S. courts find this evidence to be sufficient proof of causation.

Previous ArticleAdvair Lawsuits Next ArticleFDA Asks For Black Box Warning On Zoloft Label
Verdicts and Settlements
Contact Us

Subscribe Now!

[contact-form-7 404 "Not Found"]

Follow Us!

Unsafe Drugs has numerous resources on drug side effects,nutritional supplements, vitamins, and health products.

Site best viewed in Google Chrome, Firefox, Opera, Safari, IE browsers